137 related articles for article (PubMed ID: 38411300)
21. Malformations in newborns associated to anticonvulsant consumption during pregnancy. experience in third level hospital of Mexico.
Juárez-Olguín H; Belmont-Gómez A; Flores-Pérez J; Barranco-Garduño LM; Flores-Pérez C
Rev Invest Clin; 2008; 60(1):15-20. PubMed ID: 18589583
[TBL] [Abstract][Full Text] [Related]
22. Management of epilepsy during pregnancy.
Battino D; Tomson T
Drugs; 2007; 67(18):2727-46. PubMed ID: 18062721
[TBL] [Abstract][Full Text] [Related]
23. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Hunt S; Russell A; Smithson WH; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J; Craig J;
Neurology; 2008 Jul; 71(4):272-6. PubMed ID: 18645165
[TBL] [Abstract][Full Text] [Related]
24. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
[TBL] [Abstract][Full Text] [Related]
25. Congenital malformations before and after the onset of maternal epilepsy.
Shakir RA; Abdulwahab B
Acta Neurol Scand; 1991 Aug; 84(2):153-6. PubMed ID: 1950451
[TBL] [Abstract][Full Text] [Related]
26. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
[TBL] [Abstract][Full Text] [Related]
27. Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital.
Endo S; Hagimoto H; Yamazawa H; Kajihara S; Kubota S; Kamijo A; Nakajima K; Furusho R; Miyauchi T; Endo M
Epilepsia; 2004; 45 Suppl 8():42-7. PubMed ID: 15610194
[TBL] [Abstract][Full Text] [Related]
28. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982
[TBL] [Abstract][Full Text] [Related]
29. Common antiepileptic drugs in pregnancy in women with epilepsy.
Adab N; Tudur SC; Vinten J; Williamson P; Winterbottom J
Cochrane Database Syst Rev; 2004; (3):CD004848. PubMed ID: 15266543
[TBL] [Abstract][Full Text] [Related]
30. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.
Samrén EB; van Duijn CM; Koch S; Hiilesmaa VK; Klepel H; Bardy AH; Mannagetta GB; Deichl AW; Gaily E; Granström ML; Meinardi H; Grobbee DE; Hofman A; Janz D; Lindhout D
Epilepsia; 1997 Sep; 38(9):981-90. PubMed ID: 9579936
[TBL] [Abstract][Full Text] [Related]
31. Value of drug level concentrations of brivaracetam, lacosamide, and perampanel in care of people with epilepsy.
Hentschel M; Stoffel-Wagner B; Surges R; von Wrede R; Dolscheid-Pommerich RC
Epilepsia; 2024 Mar; 65(3):620-629. PubMed ID: 38158709
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
33. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Harden CL; Meador KJ; Pennell PB; Hauser WA; Gronseth GS; French JA; Wiebe S; Thurman D; Koppel BS; Kaplan PW; Robinson JN; Hopp J; Ting TY; Gidal B; Hovinga CA; Wilner AN; Vazquez B; Holmes L; Krumholz A; Finnell R; Hirtz D; Le Guen C; ;
Neurology; 2009 Jul; 73(2):133-41. PubMed ID: 19398681
[TBL] [Abstract][Full Text] [Related]
34. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial.
Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S;
Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101
[TBL] [Abstract][Full Text] [Related]
35. Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates.
Alsaadi T; Kassie S; Farook F; Nasreddine W; Wani S; Saleh B
Epilepsy Res; 2020 Jan; 159():106259. PubMed ID: 31901526
[TBL] [Abstract][Full Text] [Related]
36. Old and new anti-epileptic drugs in pregnancy.
Regesta G; Tanganelli P
Saudi Med J; 2000 Jan; 21(1):18-23. PubMed ID: 11533745
[TBL] [Abstract][Full Text] [Related]
37. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations.
Scheuerle AE; Holmes LB; Albano JD; Badalamenti V; Battino D; Covington D; Harden C; Miller D; Montouris GD; Pantaleoni C; Thorp J; Tofighy A; Tomson T; Golembesky AK
Birth Defects Res; 2019 Aug; 111(13):872-887. PubMed ID: 31124321
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
39. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
40. Twelve-Month Efficacy of Lacosamide Monotherapy at Maximal Dose and Tolerability for Epilepsy Treatment in Pediatric Patients: Real-World Clinical Experience.
Zhao T; Li HJ; Zhang HL; Yu J; Feng J; Wang TT; Sun Y; Yu LH
Pediatr Neurol; 2023 May; 142():23-30. PubMed ID: 36868054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
